Kim Le, Pharm.D.
Interim Senior Vice President and Chief Pharmacy Officer, National Pharmacy Services, Kaiser Permanente
is the Interim Senior Vice President and Chief Pharmacy Officer, National Pharmacy Services, Kaiser Permanente
Marta E. Wosińska, Ph.D.
Senior Fellow, Center on Health Policy, The Brookings Institution
Senior Fellow, Center on Health Policy, The Brookings Institution
Leigh Purvis, MPA
Prescription Drug Policy Principal, AARP Public Policy Institute
Leigh Purvis, Prescription Drug Policy Principal, AARP Public Policy Institute
Kristi Martin, MA, MPA
President, Highway 136 Consulting, Director, Camber Collective
Kristi Martin is a seasoned health policy expert with over 20 years of experience in the public sector, private sector,…
Jerry Avorn, MD
Professor of Medicine, Harvard Medical School, Chief Emeritus, Division of Pharmacoepidemiology and Pharmacoeconomics, Co-Director, Program on Regulation, Therapeutics, and Law
Professor of Medicine, Harvard Medical School, Chief Emeritus, Division of Pharmacoepidemiology and Pharmacoeconomics, Co-Director, Program on Regulation, Therapeutics, and Law
Conor Sheehey
Director, Leavitt Partners, Former Senior Health Counsel, U.S. Senate Committee on Finance
Conor Sheehey, Director, Leavitt Partners, Former Senior Health Counsel, U.S. Senate Committee on Finance
Lauren Aronson
Lauren Aronson, Executive Director, Campaign for Sustainable Drug Pricing (CSRxP), Partner, Mehlman Consulting
Lauren Aronson, Executive Director, Campaign for Sustainable Drug Pricing (CSRxP). Partner, Melman Consulting
Tahir Amin, LL.B., Dip. LP.
CEO, Initiative for Medicines, Access & Knowledge (I-MAK)
CEO, Initiative for Medicines, Access & Knowledge (I-MAK)
Adriane Fugh-Berman, MD
Director, PharmedOut, Professor, Georgetown University Medical Center
Adriene Fugh-Berman, MD, Professor, Georgetown University Medical Center, Director, PharmedOut
Polly Webster, JD, MPH
Senior Health Counsel, US Senate Committee on Finance
Senior Health Counsel, Senate Committee on Finance